Showing results (451-460 of 1,028) with videos related to
Sort By:
Pageof 103
The Lancet. Respiratory Medicine|November 30, 2024
Associations between life-course FEV1/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studiesJennifer L Perret, Dinh S Bui, Carrie Pistenmaa, et al.The Lancet. Respiratory Medicine|October 21, 2024
Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet. Respiratory Medicine|July 18, 2024
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validationHernan P Fainberg, Yuben Moodley, Isaac Triguero, et al.The Lancet. Respiratory Medicine|August 15, 2024
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trialJiayi Yu, Leilei Jiang, Lina Zhao, et al.The Lancet. Respiratory Medicine|September 2, 2024
Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trialSurinder S Birring, Linda Cardozo, Roger Dmochowski, et al.The Lancet. Respiratory Medicine|August 31, 2024
An international consensus on the use of asthma biologics in pregnancyJennifer Naftel, David J Jackson, Matthew Coleman, et al.The Lancet. Respiratory Medicine|June 14, 2024
Hypothermia for expanded criteria organ donors in kidney transplantation in France (HYPOREME): a multicentre, randomised controlled trialThe Lancet. Respiratory Medicine|April 28, 2024
Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trialJohn Lowe, David Gillespie, Ali Aboklaish, et al.The Lancet. Respiratory Medicine|April 27, 2024
Chronic respiratory disease in Indigenous peoples: a framework to address inequity and strengthen respiratory health and health care globallyAnne B Chang, Tom Kovesi, Gregory J Redding, et al.The Lancet. Respiratory Medicine|June 13, 2024
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trialZiming Li, Xiaomin Dang, Dingzhi Huang, et al.Pageof 103